Ethical considerations in AI-enabled electrocardiography: a narrative review
Frontiers in Cardiovascular Medicine · 19.11.2026 · 13
DOI: 10.3389/fcvm.2026.1971035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 19.11.2026. Verfasst von Vivian C. Wu und 1 weiteren Autor:innen. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Artificial intelligence (AI)-enabled electrocardiography (ECG) can detect arrhythmias, structural abnormalities, and physiological patterns not readily apparent through conventional interpretation. However, its rapid clinical integration raises ethical concerns. This review critically synthesizes literature on bias and fairness, privacy and confidentiality, explainability and transparency, clinical trust and automation bias, and governance and accountability.
Methods
We conducted a narrative review using structured searches of PubMed, Embase, and Web of Science. Review preparation was informed by the SANRA quality-assessment scale, and study selection was summarized using a flow diagram adapted from PRISMA-ScR (435 records identified; 46 studies included). Studies were eligible if they substantively examined ethical considerations in AI-ECG; those addressing technical performance alone were excluded. Evidence was classified by study design and clinical maturity.
Results
Ethical risks arose throughout the AI-ECG lifecycle, beyond the algorithm itself. Studies documented performance disparities across sex, age, race, and ethnicity, alongside vulnerabilities involving membership inference, biometric re-identification, and unintended attribute inference. Explainability remained inadequately evaluated, while automation bias raised concerns about clinical decision-making and patient safety. Governance and post-deployment oversight remained fragmented. Most quantitative evidence came from retrospective or experimental proof-of-concept studies rather than externally validated or clinically deployed systems.
Discussion
Responsible AI-ECG implementation requires a lifecycle approach addressing upstream bias, privacy safeguards, clinically meaningful explanations, clinician oversight, and post-deployment surveillance. We propose Inherent Protocol Bias (IPB) as an organizing framework linking downstream ethical risks to decisions in study design, data collection, validation, and deployment. Unlike dataset bias, selection bias, spectrum bias, measurement bias, and cohort-origin confounding, which describe specific sources or manifestations of error, IPB emphasizes the protocol-level decisions through which established biases arise or persist. IPB is not a new statistical form of bias but a framework for identifying actionable intervention points. We outline potential applications for improving fairness, privacy, accountability, and clinical trust; however, these recommendations remain conceptual and require empirical evaluation.
Zitieren
APA
Wu, V. C., & Rabkin, S. W. (2026). Ethical considerations in AI-enabled electrocardiography: a narrative review. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1971035
Vancouver
Wu VC, Rabkin SW. Ethical considerations in AI-enabled electrocardiography: a narrative review. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1971035
BibTeX
@article{Wu2026,
author = {Wu, Vivian C. and Rabkin, Simon W.},
title = {Ethical considerations in AI-enabled electrocardiography: a narrative review},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1971035}
}
EUVIMED